These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 9181467

  • 1. Obstruction of HIV-1 particle release by interferon-alpha occurs before viral protease processing and is independent of envelope glycoprotein.
    Babé LM, Unal A, Craik CS.
    J Interferon Cytokine Res; 1997 May; 17(5):287-93. PubMed ID: 9181467
    [Abstract] [Full Text] [Related]

  • 2. Interferon treatment inhibits virus replication in HIV-1- and SIV-infected CD4+ T-cell lines by distinct mechanisms: evidence for decreased stability and aberrant processing of HIV-1 proteins.
    Agy MB, Acker RL, Sherbert CH, Katze MG.
    Virology; 1995 Dec 20; 214(2):379-86. PubMed ID: 8553538
    [Abstract] [Full Text] [Related]

  • 3. Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid.
    Wiegers K, Rutter G, Schubert U, Grättinger M, Kräusslich HG.
    Virology; 1999 Apr 25; 257(1):261-74. PubMed ID: 10208939
    [Abstract] [Full Text] [Related]

  • 4. The 3-O-(3',3'-dimethylsuccinyl) derivative of betulinic acid (DSB) inhibits the assembly of virus-like particles in HIV-1 Gag precursor-expressing cells.
    DaFonseca S, Blommaert A, Coric P, Hong SS, Bouaziz S, Boulanger P.
    Antivir Ther; 2007 Apr 25; 12(8):1185-203. PubMed ID: 18240859
    [Abstract] [Full Text] [Related]

  • 5. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
    Fitzon T, Leschonsky B, Bieler K, Paulus C, Schröder J, Wolf H, Wagner R.
    Virology; 2000 Mar 15; 268(2):294-307. PubMed ID: 10704338
    [Abstract] [Full Text] [Related]

  • 6. In vitro processing of human immunodeficiency virus type 1 Gag virus-like particles.
    Morikawa Y, Shibuya M, Goto T, Sano K.
    Virology; 2000 Jul 05; 272(2):366-74. PubMed ID: 10873780
    [Abstract] [Full Text] [Related]

  • 7. The role of nucleocapsid of HIV-1 in virus assembly.
    Dawson L, Yu XF.
    Virology; 1998 Nov 10; 251(1):141-57. PubMed ID: 9813210
    [Abstract] [Full Text] [Related]

  • 8. HIV-1 gag proteins: diverse functions in the virus life cycle.
    Freed EO.
    Virology; 1998 Nov 10; 251(1):1-15. PubMed ID: 9813197
    [Abstract] [Full Text] [Related]

  • 9. A human cell line constitutively expressing HIV-1 Gag and Gag-Pol gene products.
    Wang CT, Li JJ, Lai HY, Hu BS.
    J Med Virol; 1999 Jan 10; 57(1):17-24. PubMed ID: 9890417
    [Abstract] [Full Text] [Related]

  • 10. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
    Müller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Kräusslich HG.
    J Virol; 2004 Oct 10; 78(19):10803-13. PubMed ID: 15367647
    [Abstract] [Full Text] [Related]

  • 11. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease.
    Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM.
    Virology; 2002 Jan 05; 292(1):137-49. PubMed ID: 11878916
    [Abstract] [Full Text] [Related]

  • 12. Human immunodeficiency virus type 1 assembly, release, and maturation.
    Adamson CS, Freed EO.
    Adv Pharmacol; 2007 Jan 05; 55():347-87. PubMed ID: 17586320
    [No Abstract] [Full Text] [Related]

  • 13. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
    Haglund K, Forman J, Kräusslich HG, Rose JK.
    Virology; 2000 Mar 01; 268(1):112-21. PubMed ID: 10683333
    [Abstract] [Full Text] [Related]

  • 14. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles.
    Chen SW, Chiu HC, Liao WH, Wang FD, Chen SS, Wang CT.
    Virology; 2004 Jan 20; 318(2):534-41. PubMed ID: 14972522
    [Abstract] [Full Text] [Related]

  • 15. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M, Lemay G, Cohen EA.
    Virus Res; 2007 Mar 20; 124(1-2):103-12. PubMed ID: 17129629
    [Abstract] [Full Text] [Related]

  • 16. Interferon downregulates CXCR4 (fusin) gene expression in peripheral blood mononuclear cells.
    Shirazi Y, Pitha PM.
    J Hum Virol; 1998 Mar 20; 1(2):69-76. PubMed ID: 10195234
    [Abstract] [Full Text] [Related]

  • 17. Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.
    Liao WH, Wang CT.
    Virology; 2004 Nov 10; 329(1):180-8. PubMed ID: 15476885
    [Abstract] [Full Text] [Related]

  • 18. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY, Luo L, Wainberg MA, Li Y.
    Biol Chem; 1999 Mar 10; 380(3):353-64. PubMed ID: 10223338
    [Abstract] [Full Text] [Related]

  • 19. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C, Santini SM, Proietti E, Rizza P, Logozzi M, Spada M, Parlato S, Fais S, Pitha PM, Belardelli F.
    Virology; 1999 Oct 10; 263(1):78-88. PubMed ID: 10544084
    [Abstract] [Full Text] [Related]

  • 20. Constitutive production of nonenveloped human immunodeficiency virus type 1 particles by a mammalian cell line and effects of a protease inhibitor on particle maturation.
    Babé LM, Craik CS.
    Antimicrob Agents Chemother; 1994 Oct 10; 38(10):2430-9. PubMed ID: 7840583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.